Clinical trials recruiting for Prostate Cancers

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Comprehensive Outcomes for After Cancer Health
  NCT05349227 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
  NCT06926075 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.
  NCT06776172 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 15 locations
• FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
  NCT06636682 · Phase: Phase 2 · Ages: No age limits stated · Sex: Male · 3 locations
• Ivonescimab in the Treatment of Multiple Advanced Tumors
  NCT06683846 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PRostate Cancer Enhanced Diagnosis by Calibration Technology
  NCT06607783 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial
  NCT06915909 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Male · 1 location
• Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
  NCT06960291 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
  NCT06717295 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · 8 locations
• To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
  NCT06970275 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Using FAPI PET/MRI to Evaluate Prostate Cancer
  NCT06675357 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Prostate Cancers often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Prostate Cancers trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.